Provided by Tiger Fintech (Singapore) Pte. Ltd.

Sonoma Pharmaceuticals, Inc.

2.13
+0.02000.95%
Volume:15.28K
Turnover:32.85K
Market Cap:3.44M
PE:-0.46
High:2.25
Open:2.09
Low:2.05
Close:2.11
Loading ...

Sonoma Pharmaceuticals to Exhibit at 2025 American Academy of Dermatology Annual Meeting in Orlando

ACCESS Newswire
·
26 Feb

More Musk-like 'Dexits' pose fresh threat to Delaware's corporation crown

Yahoo Finance
·
15 Feb

Sonoma Pharmaceuticals Third Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag

Simply Wall St.
·
07 Feb

Sonoma Pharmaceuticals Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
07 Feb

Sonoma Pharmaceuticals Q3 2025 GAAP EPS $(0.63) Beats $(0.69) Estimate, Sales $3.564 Miss $4.060M Estimate

Benzinga
·
06 Feb

Sonoma Pharmaceuticals Inc expected to post a loss of 69 cents a share - Earnings Preview

Reuters
·
05 Feb

Sonoma transitions first products to new EU MDR requirements

TIPRANKS
·
05 Dec 2024

BRIEF-Sonoma Pharmaceuticals Terminates Supply And Distribution Agreement With EMC Pharma

Reuters
·
22 Nov 2024

Sonoma Pharmaceuticals Inc - to Resume Selling Acuicyn, Celacyn, Epicyn, Lasercyn, Levicyn in U.S.

THOMSON REUTERS
·
22 Nov 2024

Sonoma Pharmaceuticals Inc - Terminates Supply and Distribution Agreement With Emc Pharma

THOMSON REUTERS
·
22 Nov 2024

Sonoma Pharmaceuticals announces relaunch of dermatology, eye care lines

TIPRANKS
·
22 Nov 2024

Sonoma Pharmaceuticals Second Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag

Simply Wall St.
·
12 Nov 2024

Sonoma Pharmaceuticals Gets FDA Clearance for Hydrogel Wound Treatment

MT Newswires Live
·
12 Nov 2024

FDA grants Sonoma 510(k) approval for Microdacyn Hydrogel

TIPRANKS
·
11 Nov 2024

Sonoma Pharmaceuticals Second Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag

Simply Wall St.
·
09 Nov 2024

Sonoma Pharmaceuticals Inc expected to post a loss of 80 cents a share - Earnings Preview

Reuters
·
09 Nov 2024